The forecast for bladder malignant neoplasms mortality among females in Japan shows a stabilized standardised rate of 1.9 deaths per 100,000 women from 2024 through 2028. This indicates no expected year-on-year variation from the 2023 level. Over this period, the lack of change reflects a zero percent compound annual growth rate (CAGR), pointing to a steady pattern without decline or increase in mortality rates.
Future trends to watch for include advances in medical treatments and early detection methods, which could potentially reduce mortality rates. Additionally, shifts in healthcare policies or demographic trends might impact future forecasts and should be closely monitored.
